Adenosine receptor activation ameliorates type 1 diabetes
Open Access
- 3 April 2007
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 21 (10) , 2379-2388
- https://doi.org/10.1096/fj.07-8213com
Abstract
Growing evidence indicates that adenosine receptors could be promising therapeutic targets in autoimmune diseases. Here we studied the role of adenosine receptors in controlling the course of type 1 ...Keywords
Funding Information
- National Institutes of Health (R01 GM66189)
- National Institute on Alcohol Abuse and Alcoholism
- Hungarian Scientific Research Fund (T 049537)
This publication has 42 references indexed in Scilit:
- Vascular Reactivity in Arterioles From Normal and Alloxan-Diabetic MiceDiabetes, 2007
- The A2B adenosine receptor protects against inflammation and excessive vascular adhesionJournal of Clinical Investigation, 2006
- Adenosine: an endogenous regulator of innate immunityTrends in Immunology, 2004
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- Effect of γ-butyrobetaine on fatty liver in juvenile visceral steatosis miceJournal of Pharmacy and Pharmacology, 2001
- LOCAL BLOOD FLOW REGULATION IN TRANSPLANTED RAT PANCREATIC ISLETSTransplantation, 2000
- A2A adenosine receptors in human peripheral blood cellsBritish Journal of Pharmacology, 2000
- Prevention of diabetes in NOD mice treated with antibody to murine IFNγJournal of Autoimmunity, 1991
- Differential inhibition of lymphocyte function by 2-chloroadenosineInternational Journal of Immunopharmacology, 1984
- Regulation of thymocyte proliferation by endogenous adenosine and adenosine deaminaseInternational Journal of Immunopharmacology, 1983